Showing results (491-500 of 527) with videos related to

Sort By:
Pageof 53
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 29, 2023
Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune responseAntonio Jesús Ruiz-Malagón, Laura Hidalgo-García, María Jesús Rodríguez-Sojo, et al.
Journal of Crohn'S & Colitis|December 12, 2018
Lack of the pH-sensing Receptor TDAG8 [GPR65] in Macrophages Plays a Detrimental Role in Murine Models of Inflammatory Bowel DiseaseIrina Tcymbarevich, Shola M Richards, Giancarlo Russo, et al.
Mucosal Immunology|February 12, 2019
The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitisAnnika Wyss, Tina Raselli, Nathan Perkins, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 28, 2025
Relapse rate following withdrawal of vedolizumab and ustekinumab in patients with inflammatory bowel disease - a multicenter retrospective controlled study. The VEDUST-EXIT StudyAhmad Albshesh, Piotr Kucha, Daniela Pugliese, et al.
Journal of Crohn'S & Colitis|August 31, 2018
Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to FibrogenesisSenta Hutter, Wouter T van Haaften, Anouk Hünerwadel, et al.
Inflammatory Intestinal Diseases|July 19, 2018
Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)Ekaterina Safroneeva, Catherine Saner, Jean-Benoît Rossel, et al.
Journal of Crohn'S & Colitis|September 24, 2016
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special SituationsPaolo Gionchetti, Axel Dignass, Silvio Danese, et al.
The Journal of Clinical Investigation|October 1, 2020
Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer developmentEgle Katkeviciute, Larissa Hering, Ana Montalban-Arques, et al.
Inflammatory Bowel Diseases|July 28, 2021
New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4Bruce Weder, Fabian Schefer, Wouter Tobias van Haaften, et al.
Inflammatory Bowel Diseases|April 29, 2017
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort StudyStephan R Vavricka, Martin Gubler, Claudine Gantenbein, et al.
Pageof 53